Product Pipeline

Paras - Product Pipeline

Category
Product/ Biosimilars Technology
Technology Platform
Osteoporosis PB Osteo-1010 (Biosimilar) Diabrid Technology/ NobleCleav® Technology
Rheumatoid Arthritis PB (RA)- 2010 ( Biosimilar) High Expression Technology
Metabolic Disorders PB (MDT)- 3010 (Biosimilar) Diabrid Technology/ NobleCleav® Technology
Metabolic Disorders PB (MDT)- 3020 ( Biosimilar) Diabrid Technology/ NobleCleav® Technology
Metabolic Disorders PB (MDT)- 3030 ( Biosimilar) High Expression Technology
Metabolic Disorders PB (MDT)- 3040 ( Biosimilar) Diabrid Technology/ NobleCleav® Technology
Oncology PPB (CT)- 4010 Under Development
Oncology PB (CT)- 4020 Under Development
Paras - Product Under Development

Biopharma Products

Disclaimer

Products under patents are part of our research projects. These products may be offered only in those countries where patents have expired.

For the latest status, please contact Paras Biopharmaceuticals Finland Oy.






































Company Presentation 2018

Company Presentation 2016

Company Presentation 2014

Company Presentation 2012

Meet Us At

Connect with us

Paras Biopharmaceuticals
Finland Oy
,

Kiviharjunlenkki 10, OULU,
FI-90220 Finland

P: +358 442709462

Dr Ashesh Kumar
E: kumar.ashesh@parasbiopharma.com
P: +358 (0) 400207380

Dr Upendra Khurana
E: upendra.khurana@parasbiopharma.com
P:+358 (0) 449783160

Dr Mark Jackson
E: mark.jackson@parasbiopharma.com
P:+358 (0) 442905993

Skype: Paras.Finland